The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection

Takeshi Sasaki, Koji Arakawa, Kiyoshi Shimada, Noboru Saito

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effects of highly selective antagonists to μ-, δ-, and κ-opioid receptor subtypes on hyperosmotic- or angiotensin II (AII)-induced arginine vasotocin (AVT) release were investigated in chicks. Plasma levels of AVT increased about 1.5-fold after the administration of 1.5 M NaCl (200 μl, ip) or 100 ng AII (5 μl, icv). The administration of the μ-antagonist naloxonazine and the κ-antagonist nor-Binaltorphimine further elevated plasma levels of AVT stimulated by hypertonic NaCl or AII. These effects of μ- and κ-opioid receptor antagonists on AVT release were dose dependent. Nor-Binahorphimine enhanced hyperosmotically stimulated plasma levels of AVT at a lower dose than that of naloxonazine. Conversely, the δ-selective antagonist naltrindole did not significantly affect AVT secretion. None of the opioid receptor antagonists influenced basal plasma levels of AVT. Therefore, these results suggest that μ- and δ-opioid receptors are involved in hyperosmotic- and AII-induced AVT release, and the effect of the κ-opioid receptor antagonist in the AVT release stimulated by hyperosmolality is strong compared to that of the μ-opioid receptor antagonist, (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)365-372
Number of pages8
JournalGeneral and Comparative Endocrinology
Volume118
Issue number3
DOIs
Publication statusPublished - Jun 2000
Externally publishedYes

Fingerprint

arginine vasotocin
Vasotocin
Narcotic Antagonists
angiotensin II
narcotics
Angiotensin II
antagonists
injection
receptors
Injections
naltrindole
Opioid Receptors
dosage
chicks
secretion

Keywords

  • Angiotensin II
  • Arginine vasotocin
  • Chicks
  • Hypertonic stimulation
  • Naloxonazine
  • Naltrindole
  • Nor-BNI
  • Opioid receptor

ASJC Scopus subject areas

  • Endocrinology

Cite this

The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection. / Sasaki, Takeshi; Arakawa, Koji; Shimada, Kiyoshi; Saito, Noboru.

In: General and Comparative Endocrinology, Vol. 118, No. 3, 06.2000, p. 365-372.

Research output: Contribution to journalArticle

@article{15d589e5fe6e4a81976c522fb1c6db70,
title = "The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection",
abstract = "The effects of highly selective antagonists to μ-, δ-, and κ-opioid receptor subtypes on hyperosmotic- or angiotensin II (AII)-induced arginine vasotocin (AVT) release were investigated in chicks. Plasma levels of AVT increased about 1.5-fold after the administration of 1.5 M NaCl (200 μl, ip) or 100 ng AII (5 μl, icv). The administration of the μ-antagonist naloxonazine and the κ-antagonist nor-Binaltorphimine further elevated plasma levels of AVT stimulated by hypertonic NaCl or AII. These effects of μ- and κ-opioid receptor antagonists on AVT release were dose dependent. Nor-Binahorphimine enhanced hyperosmotically stimulated plasma levels of AVT at a lower dose than that of naloxonazine. Conversely, the δ-selective antagonist naltrindole did not significantly affect AVT secretion. None of the opioid receptor antagonists influenced basal plasma levels of AVT. Therefore, these results suggest that μ- and δ-opioid receptors are involved in hyperosmotic- and AII-induced AVT release, and the effect of the κ-opioid receptor antagonist in the AVT release stimulated by hyperosmolality is strong compared to that of the μ-opioid receptor antagonist, (C) 2000 Academic Press.",
keywords = "Angiotensin II, Arginine vasotocin, Chicks, Hypertonic stimulation, Naloxonazine, Naltrindole, Nor-BNI, Opioid receptor",
author = "Takeshi Sasaki and Koji Arakawa and Kiyoshi Shimada and Noboru Saito",
year = "2000",
month = "6",
doi = "10.1006/gcen.2000.7470",
language = "English",
volume = "118",
pages = "365--372",
journal = "General and Comparative Endocrinology",
issn = "0016-6480",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection

AU - Sasaki, Takeshi

AU - Arakawa, Koji

AU - Shimada, Kiyoshi

AU - Saito, Noboru

PY - 2000/6

Y1 - 2000/6

N2 - The effects of highly selective antagonists to μ-, δ-, and κ-opioid receptor subtypes on hyperosmotic- or angiotensin II (AII)-induced arginine vasotocin (AVT) release were investigated in chicks. Plasma levels of AVT increased about 1.5-fold after the administration of 1.5 M NaCl (200 μl, ip) or 100 ng AII (5 μl, icv). The administration of the μ-antagonist naloxonazine and the κ-antagonist nor-Binaltorphimine further elevated plasma levels of AVT stimulated by hypertonic NaCl or AII. These effects of μ- and κ-opioid receptor antagonists on AVT release were dose dependent. Nor-Binahorphimine enhanced hyperosmotically stimulated plasma levels of AVT at a lower dose than that of naloxonazine. Conversely, the δ-selective antagonist naltrindole did not significantly affect AVT secretion. None of the opioid receptor antagonists influenced basal plasma levels of AVT. Therefore, these results suggest that μ- and δ-opioid receptors are involved in hyperosmotic- and AII-induced AVT release, and the effect of the κ-opioid receptor antagonist in the AVT release stimulated by hyperosmolality is strong compared to that of the μ-opioid receptor antagonist, (C) 2000 Academic Press.

AB - The effects of highly selective antagonists to μ-, δ-, and κ-opioid receptor subtypes on hyperosmotic- or angiotensin II (AII)-induced arginine vasotocin (AVT) release were investigated in chicks. Plasma levels of AVT increased about 1.5-fold after the administration of 1.5 M NaCl (200 μl, ip) or 100 ng AII (5 μl, icv). The administration of the μ-antagonist naloxonazine and the κ-antagonist nor-Binaltorphimine further elevated plasma levels of AVT stimulated by hypertonic NaCl or AII. These effects of μ- and κ-opioid receptor antagonists on AVT release were dose dependent. Nor-Binahorphimine enhanced hyperosmotically stimulated plasma levels of AVT at a lower dose than that of naloxonazine. Conversely, the δ-selective antagonist naltrindole did not significantly affect AVT secretion. None of the opioid receptor antagonists influenced basal plasma levels of AVT. Therefore, these results suggest that μ- and δ-opioid receptors are involved in hyperosmotic- and AII-induced AVT release, and the effect of the κ-opioid receptor antagonist in the AVT release stimulated by hyperosmolality is strong compared to that of the μ-opioid receptor antagonist, (C) 2000 Academic Press.

KW - Angiotensin II

KW - Arginine vasotocin

KW - Chicks

KW - Hypertonic stimulation

KW - Naloxonazine

KW - Naltrindole

KW - Nor-BNI

KW - Opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=0034044787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034044787&partnerID=8YFLogxK

U2 - 10.1006/gcen.2000.7470

DO - 10.1006/gcen.2000.7470

M3 - Article

VL - 118

SP - 365

EP - 372

JO - General and Comparative Endocrinology

JF - General and Comparative Endocrinology

SN - 0016-6480

IS - 3

ER -